Evidence map›Paper›PMID 40839395›Full record

ArticleJournal of the National Cancer Institute2025

Tattooing and risk of melanoma: a population-based case-control study in Utah.

Rachel D McCarty, Britton Trabert, Lindsay J Collin, Morgan M Millar, David Kriebel, Laurie Grieshober, Mollie E Barnard, Jenna Sawatzki, Marjorie Carter, Valerie Yoder and 5 more

Abstract read
In one paragraph

Article in Journal of the National Cancer Institute, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Is tattooing associated with an increased risk of cancer? A systematic review and meta-analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Rachel D McCartyHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.ORCID 0000-0003-2742-3081
Britton TrabertHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.ORCID 0000-0002-1539-6090
Lindsay J CollinHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.ORCID 0000-0003-0170-2592
Morgan M MillarHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.ORCID 0000-0001-5532-6970
David KriebelLowell Center for Sustainable Production, University of Massachusetts Lowell, Lowell, MA, United States.ORCID 0000-0003-1246-6142
Laurie GrieshoberHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.ORCID 0000-0003-2316-9143
Mollie E BarnardHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.ORCID 0000-0002-4843-4655
Jenna SawatzkiHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.
Marjorie CarterUtah Cancer Registry, University of Utah, Salt Lake City, UT, United States.ORCID 0009-0005-8780-6916
Valerie YoderUtah Cancer Registry, University of Utah, Salt Lake City, UT, United States.ORCID 0009-0005-6150-8072
Jeffrey A GilreathHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.ORCID 0000-0002-4566-8448
Douglas GrossmanHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.ORCID 0000-0003-1790-7023
John HyngstromHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.ORCID 0000-0002-4833-3838
Paul J ShamiHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.ORCID 0000-0002-5696-6512
Jennifer A DohertyHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.ORCID 0000-0002-1454-8187

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI KATHARINE S ULLMAN · 1986 to 2026
$72.6M
Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
CTSA Predoctoral T32 at University of Utah: Spheres of Translation Across the Research Spectrum (STARS) Training ProgramT32TR004392 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI ANGELA FAGERLIN, Keke Celeste Fairfax · 2023 to 2026
$1.3M
Identifying factors associated with ovarian cancer recurrence using a population-based approachR00CA277580 · NCI · EMORY UNIVERSITY · PI Lindsay Jane Collin · 2025 to 2026
$457k
Inflammation and gynecologic cancer: the role of prostaglandins in ovarian cancerK00CA212222 · NCI · UNIVERSITY OF UTAH · PI BARNARD, MOLLIE ELYSE · 2018 to 2021
$415k
Cancer Control and Population SciencesCDC HHS NU58DP007131Huntsman Cancer FoundationHuntsman Cancer InstituteHuntsman Cancer Institute Melanoma Disease CenterNCATSNCATS NIH HHS T32 TR004392NCATS NIH HHS UL1 TR002538NCI NIH HHS HHSN261201800016CNCI NIH HHS HHSN261201800016INCI NIH HHS K00 CA212222NCI NIH HHS P30 CA042014NCI NIH HHS R00 CA277580NCI NIH HHS R00CA277580NIHNIH HHS K00CA212222NIH HHS P30CA042014NIH HHS T32TR004392University of Utah and Huntsman Cancer Foundation UL1TR002538World Health Organization 001
6 · The paper itself

Abstract

backgroundTattooing can deliver carcinogens directly into the skin and cause immunological responses, and yet the relationship between tattooing and melanoma risk is unknown.

methodsIn a population-based case-control study with 1167 melanoma cases (566 in situ; 601 invasive) and 5835 frequency-matched controls, we examined tattooing and melanoma risk using multivariable logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CIs).

resultsAlthough ever receiving a tattoo was not strongly associated with melanoma risk, heavier tattooing exposure was associated with decreased risk. Overall melanoma risk was decreased among individuals who had received 4 or more tattoo sessions (OR = 0.44, 95% CI = 0.27 to 0.67) and individuals who had 3 or more large tattoos (OR = 0.26, 95% CI = 0.10 to 0.54) compared with those who were never tattooed. Invasive melanoma risk was also decreased among individuals who received their first tattoo before age 20 (OR = 0.48, 95% CI = 0.29 to 0.82) compared with never tattooed individuals.

conclusionsOur findings suggest that more tattoo exposure is associated with reduced melanoma risk, which does not support previously hypothesized associations between tattooing and increased melanoma risk. Unmeasured confounding is likely to contribute to our findings because we were not able to control for important melanoma risk factors. Potential causes of these associations could include sun exposure-related behaviors or immune responses to tattooing. Further investigation is warranted to clarify these relationships.

Indexed as

MelanomaSkin NeoplasmsTattooingAdultAgedCase-Control StudiesFemaleHumansLogistic ModelsMaleMiddle AgedOdds RatioRisk AssessmentRisk FactorsUtah

Identifiers

PMID40839395
PMCPMC12404683

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.